needed effects
streptokinase
active ingredient
streptase
unwanted side effects
medical attention
following side effects
taking streptokinase
check
doctor
nurse
predisposing risk factors for the development of intracranial hemorrhage during thrombolytic therapy for myocardial infarction
body weight
kg
age
years
preexisting
preexisting anticoagulant therapy
authors of gissi
risk of hemorrhagic stroke
killip classification
meta-analysis of studies
proximal lower extremity
deep vein thrombosis
dvt
following
following relative risks for patients
sk
heparin
heparin
major bleeding
central nervous system
cns
bleeding
mortality from cns bleeding
pulmonary embolism
pe
mortality from pe
postphlebitic syndrome
risk of hemorrhagic side effects from streptokinase
active ingredient
streptase
patient selection
major risk factors for intracranial hemorrhage
known intracranial tumor
neurosurgery
stroke within the past
months
head trauma within the past month
other significant risk factors
uncontrolled hypertension
remote stroke
recent transient ischemic attacks
age
female gender
hematologic side effects of streptokinase
sk
major bleeding
risk of bleeding
plasma fibrinogen levels
mg/dl
minor bleeding
patients
presenting as venipuncture
arterial cutdown site
microscopic hematuria
hemoptysis
hematemesis
local bleeding
manual compression
minutes
major bleeding
including
retroperitoneal
intracerebral hemorrhage
patients
adjuvant heparin
aspirin
therapy
risk of bleeding
intracranial hemorrhage
patients
rare cases of intramyocardial hemorrhage
several fatalities
retroperitoneal hemorrhage
thrombolytic therapy
rare cases of embolization
anti-sk-mediated platelet aggregation
sk therapy
speculation that fibrinolysis
pericatheter thrombosis
distal thromboembolism
overall incidence of hypersensitivity reactions
sk from the isis
gissi
gissi
data
smaller studies
incidence
acute allergic reactions
sk
minor dyspnea
urticaria
pruritus
flushing
nausea
headache
musculoskeletal pain
severe anaphylaxis
bronchospasm
angioneurotic edema
sk-induced fever
patients
severe acute hypersensitivity reactions
required discontinuation of therapy
antihistamines
corticosteroids
rare cases
adrenergic agents
anaphylactic shock
patients in the isis
trial
sk
confirmed incidences of anaphylactic shock
gissi study incidents of nonfatal anaphylactic reactions
patients
received sk
patients
allergic reactions
therapy
skin testing
sk therapy
specific tool
patients at risk for anaphylaxis
cardiovascular side effects
population of patients
sk
cause-and-effect relationship
drug
transient hypotension
sk therapy
patients
inferior wall mi
hypotension
reperfusion
decreased in-hospital mortality
reperfusion of the myocardium
arrhythmias
patients
reperfusion
common reperfusion arrhythmia
transient accelerated idioventricular rhythm
premature ventricular depolarizations during reperfusion
severe ventricular arrhythmias
dyspnea
cyanosis
rare cases of hemorrhagic myocardial infarction
serious ventricular arrhythmias
hemopericardium
death from cardiogenic shock
thrombolytic therapy
rare cases of cholesterol embolization syndrome
sk
other thrombolytic agents
cholesterol embolization
rare syndrome
painful ischemia
necrosis of the digits
myalgias
skin changes of livedo reticularis
renal failure
death
other findings
cyanosis
ulcers
gangrene of the hands
feet
myalgias
intestinal infarction
eosinophilia
exact mechanism
physical disruption of atheromatous plaques by lysis of platelet-fibrin thrombi
new
worsened renal impairment
sk-induced immune complex disease
rare cases of mild
transient acute renal insufficiency with proteinuria without evidence of hypersensitivity
sk therapy
differential diagnosis of acute renal failure
following sk therapy
ischemic injury
immunologic injury
postrenal obstruction
ischemia
low cardiac output
hypotension
acute myocardial infarction
direct effect of sk
reperfusion-induced hypotension
hemorrhagic shock
conditions
acute tubular necrosis
ischemia
emboli from mural thrombi
cholesterol emboli syndrome
myoglobinuria
immunologic injury
kidney
sk-induced serum sickness
schonlein-henoch purpura
immune complex nephritis
retroperitoneal hemorrhage
ureter thrombosis
following sk therapy
postrenal obstruction
case of guillain-barre syndrome
gbs
sk
oligoclonal igg bands in the cerebrospinal fluid
serum
streptokinase
active ingredient
streptase
clinical symptoms of gbs
sk-antibody complex-mediated damage
local blood-nerve barrier
hemorrhagic stroke
serious nervous system side effect
patients
rare cases of guillain-barre syndrome
use of sk
gastrointestinal side effects
hemorrhagic gastritis
thrombolytic state
nausea
vomiting
thrombolytic therapy
unusual cases of hemorrhagic splenic rupture
subcapsular hepatic hematoma
rare cases of sk-induced hepatic dysfunction
experts
transient liver function test elevations
cholestasis
allergic effects of sk
high activities of the proteolytic enzymes
plasminogen activator
plasmin
rare cases of jaundice
prospective study of nonselected patients with peripheral arterial occlusions
undergoing sk therapy
significant liver enzyme elevations
cholestasis
impaired hepatocellular integrity
function
none
rare cases of musculoskeletal back pain
cases
iliopsoas muscles
most reported cases
evidence of allergy
aortic dissection
worsened myocardial infarction
retroperitoneal hemorrhage
genitourinary concern
menstruating women
thrombolytic therapy
sk
menses
drug
menses
hemostasis of the uterine endothelium after the first day of menses
arteriolar vasoconstriction
formation of fibrin
adult respiratory distress syndrome
ards
use of sk
ards
known complication of hypersensitivity
sk
dermatologic side effects
rare cases of dermal microemboli
cases
dermal necrosis
sk
formation of antibodies
delayed hypersensitivity reactions
development of immune complex disease
presenting as fever
purpuric rashes
liver function tests
arthralgias
serum sickness
syndrome
resembling adult respiratory distress syndrome
case of sk-induced direct antiglobulin
test-positive hemolysis
production of the general body symptom
fever
urokinase
mechanism of fever
fever
breakdown products of thrombi
thrombolytic drugs
side effects of streptase
fda
healthcare professional for medical advice
blurred vision
confusion
dizziness
faintness
lightheadedness
getting
lying
sitting position
fever
sweating
unusual tiredness
weakness
blood in stool
blood in urine
nose bleeds
purple spots on skin
unusual bruising
vomiting blood
abdominal pain
swelling
pain
backaches
black, tarry stools
burning
itching
redness
soreness of skin
cloudy urine
cold clammy skin
constipation
cough
coughing up blood
difficulty with breathing
difficulty with swallowing
dizziness
fast heartbeat
fast, weak pulse
feeling of warmth
decreased frequency of urination
amount of urine
headaches
hives or welts
hive-like swelling on face
eyelids
lips
tongue
throat
hands
legs
feet
sex organs
lightheadedness
muscle
bone pain
nausea and vomiting
noisy breathing
puffiness
swelling of the eyelids
eyes
face
lips
tongue
redness of the face
neck
arms
upper chest
shortness of breath
skin rash
tightness in chest
wheezing